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Abstract
Aims To describe the proportion of glucose tests with unrecorded provenance in routine primary care data and identify
the impact on clinical practice.
Methods A cross-sectional analysis was conducted of blood glucose measurements from the Royal College of General
Practitioner Research and Surveillance Centre database, which includes primary care records from >100 practices across
England and Wales. All blood glucose results recorded during 2013 were identified. Tests were grouped by provenance
(fasting, oral glucose tolerance test, random, none specified and other). A clinical audit in a single primary care practice
was also performed to identify the impact of failing to record glucose provenance on diabetes diagnosis.
Results A total of 2 137 098 people were included in the cross-sectional analysis. Of 203 350 recorded glucose
measurements the majority (117 893; 58%) did not have any provenance information. The most commonly reported
provenance was fasting glucose (75 044; 37%). The distribution of glucose values where provenance was not recorded
was most similar to that of fasting samples. The glucose measurements of 256 people with diabetes in the audit practice
(size 11 514 people) were analysed. The initial glucose measurement had no provenance information in 164 cases
(64.1%). A clinician questioned the provenance of a result in 41 cases (16.0%); of these, 14 (34.1%) required repeating.
Lack of provenance led to delays in the diagnosis of diabetes [median (range) 30 (3–614) days].
Conclusions The recording of glucose provenance in UK primary care could be improved. Failure to record provenance
causes unnecessary repeated testing, delayed diagnosis and wasted clinician time.
Diabet. Med. 00, 000–000 (2016)
Introduction
Blood glucose fluctuates considerably, with peaks after meals
or intake of sugar and carbohydrates. In diseases of blood
glucose control, particularly diabetes mellitus, the measure-
ment of blood glucose is fundamental to making the
diagnosis, but knowing the provenance of the glucose sample
is essential to be able to interpret the result. Diabetes
diagnosis can alternatively be made using glycated haemo-
globin (HbA1c) measurement [1]. In practice HbA1c is now
used for diagnosis in most people.
Primary care internationally uses computerized medical
record systems in which key data are coded [2]. The UK
currently uses the Read code system to record data, including
laboratory test results. Inputting of these data from the
laboratory is an automated process. Laboratory requests are
almost exclusively made online. The results are sent back
automatically and then the clinician files the results from a
suspense file into the clinical record. The laboratory assigns a
Read code to the result that cannot be readily changed. For
blood glucose the particular Read code used defines the
provenance of the sample to be recorded.
Concerns have previously been raised regarding the failure
to use the correct Read code to document whether recorded
glucose values are fasted samples [3]. We have also
previously reported that the majority of recorded glucose
tests used to follow up women with gestational diabetes in
primary care did not specify the type of glucose test used; 95
samples out of 146 (65%) [4].
The provenance of data is an aspect of data quality. It is
defined as ‘how data came to be’ [5]. A blood glucose record
may have come about from a number of sources, laboratory
entered or directly coded into the clinical record by the
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clinician. We searched a large database for all glucose Read
codes of different provenances; this search incorporated
codes used for laboratory results, clinician-entered glucome-
ter values and glucose tolerance tests performed at centres
other than the registered primary care centre.
Based on these previous observations, we hypothesized
that the majority of glucose samples recorded in primary care
in the UK would not be coded according to the type of test
performed. We used data collected for the Royal College of
General Practitioner Research and Surveillance Centre
(RCGP RSC) database to quantify the coding of blood
glucose test provenance and to make recommendations for
future practice based on these data. We also performed a
clinical audit in a primary care practice to identify the impact
of failing to record glucose provenance. To the best of our
knowledge, this has not been investigated previously.
Methods
We report a mixed methods study with two components:
firstly, we report a cross-sectional analysis of serum glucose
measurements in a large primary care population to identify
the proportion of tests with no provenance information and,
secondly,we report a clinical audit of the impact of deficiencies
in glucose test provenance recording in all patients with
diabetes in an individual UK primary care practice.
Cross-sectional analysis
A cross-sectional analysis, using data from a large primary
care-based population, was conducted to report the clinical
codes used to record the type of glucose sample in the
electronic patient record.
Anonymized data, collected routinely by the RCGP RSC,
were used to define the cohort. These data comprise the
electronic patient records from patients registered at >100
primary care practices across England and Wales. These
practices have been selected by the RCGP RSC to provide a
representative sample of urban, suburban and rural practices.
The primary aim of this data collection is for disease
surveillance of the incidences of influenza-like illness and
other infectious diseases [6]; however, the dataset has been
used for a number of epidemiological studies looking at both
infectious diseases and other conditions [6–9]. Data are
automatically uploaded from the patient record to the
database from all the included practices via regular data
uploads.
We identified all the blood glucose tests recorded during
2013, this included both laboratory results and tests
performed using glucometers. We included all patients in
the RCGP RSC database in this search. We did not explore
pregnancy status. Blood glucose tests were grouped by
provenance; fasting glucose, diagnostic oral glucose tolerance
test (OGTT) glucose (tests coded as occurring at 2 h as part
of an OGTT), random glucose, other provenance, and no
provenance specified. The complete codes list included for
each provenance is shown in Appendix S1.
The distribution of glucose values from tests with no
provenance was compared with the distribution of fasting
glucose, random glucose and glucose tolerance test values
using a two-sample Kolmogorov–Smirnov test (comparison
of the cumulative distributions). The kurtosis and skew for
each distribution are also reported for comparison. For this
analysis, glucose values were cleaned, removing non-numeric
and missing data. All glucose values > 36 were assumed to be
recorded in mg/dl rather than mmol/l. These values were
converted into mmol/l by dividing by 18.02. Glucose values <
1 mmol/l and > 36 mmol/l were excluded. Data outside these
ranges had a high proportion of entries likely to be the result
of data inputting errors and were therefore considered
unreliable. The number of missing results and erroneous
entries are reported.
We also report the proportion of test results which met the
diagnostic criteria for diabetes and the diagnostic criteria for
impaired fasting glucose (6.1–6.9 mmol/l) and impaired
glucose tolerance (7.8–11.0 mmol/l) [10]. All statistical
analyses were performed using the software package R
version 2.15.2.
Clinical audit
A clinical audit of all the patients with a diagnosis of diabetes
in a single primary care practice in England was undertaken
to identify whether missing glucose provenance information
had any impact on the initial diagnosis of diabetes.
People with diabetes were identified using the practice’s
disease register of people with diabetes, created as part of
pay-for-performance quality targets. All patients with dia-
betes at the practice are included on this register and the
practice has previously undertaken a clinical audit of its
diabetes register to identify miscoded, misclassified and
misdiagnosed patients, with ~6% of people with diabetes
requiring correction of coding errors [11]. After these
corrections were made, this practice provided an accurate
sample of people with diabetes.
The clinical records of all the registered people with
diabetes were reviewed by a clinician. The date of diagnosis
What’s new?
 It has previously been noted that the recording of
provenance data with glucose results is poor, but lack
of provenance data has not previously been quantified.
 We found that 58% of glucose values tested in primary
care were recorded without provenance information.
 A single audit practice showed lack of provenance
information lead to delays in diagnosis, unnecessary
repeated testing, and wasted clinician time.
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was identified and the related investigations were recorded
along with the recorded glucose provenance information
(recorded as free text and clinical Read code). Any clinician
comments regarding the provenance of glucose test and
subsequent clinical actions were also recorded using a
prepared audit pro forma.
We report the proportion of people with diabetes for whom
the diagnosis was made using serum glucose measurements,
the proportion of first and second glucose tests where glucose
provenance was not recorded or coded, and the negative
clinical impacts of failure to record glucose provenance. The
negative impacts investigated were: number of times clinicians
contacted patients to attempt to identify test provenance (as
documented in the clinical record); the number of repeat tests
undertaken because the test provenance could not be deter-
mined; and delays in diagnosis. The delay in diagnosis was
defined as the time interval between a first test suggestive of
diabetes (≥ 7.0 mmol/l), where no provenance information
was recorded, and the time of confirmation of diabetes by a
test with recorded glucose provenance or confirmation of the
diagnosis via an alternative method.
Ethical considerations
The RCGP RSC approved the conduct of the present study
using RCGP data. The audit component of the study was to
identify the quality of implementation of accepted recom-
mendations for the diagnosis of diabetes [1,10] by a volunteer
practice with direct responsibility for the care of their patients,
with collected data used to improve local patient care. The
audit was consistent with the General Medical Council
guidance for participation in audit [12] andNational Research
Ethics Service definition [13] of clinical audit.
Results
Cross-sectional analysis
The primary care records of 2 137 098 people were included
for analysis. From these records we identified 203 350 blood
glucose measurements taken between 1 January 2013 and 31
December 2013 inclusive. A total of 146 901 (6.87%) people
had one or more glucose tests coded.
No provenance was specified for the majority of glucose
tests (Table 1). The majority of codes were recorded with a
valid numerical value for fasting, diagnostic oral glucose
tolerance test (OGTT), random, and no provenance glucose
values. The most frequently used codes to record glucose
measurement were 44g., ‘plasma glucose level’ (76 905 tests;
34.5% of all recorded tests) and 44g1., ‘fasting plasma
glucose level’ (53 252 tests; 23.9% of all tests).
The distribution of glucose values for tests with unknown
provenance most closely resembles that of fasted samples,
suggesting the majority of these samples were taken with the
patient having fasted (Fig. 1 and Table 2); however, the two
distributions are significantly different; two-sample Kol-
mogorov–Smirnov statistic for comparison of the cumulative
distribution of fasting glucose tests with those of unknown
provenance D=0.3744, P<0.001. The distribution of
unknown samples was dissimilar to that of random samples;
Kolmogorov–Smirnov statistic D=0.0767, P<0.001. There
were not enough data to compare the distribution of
diagnostic OGTT glucose results and those of unknown
provenance.
Of the test results with a recorded value, 10 504 (6.0%)
were in the range for diabetes, 6661 (3.8%) were in the range
for impaired fasting glucose and 245 (0.1%) were in the
range for impaired glucose tolerance. A total of 6017 people
(4.1%) tested had one or more glucose values in the range for
diabetes when using ≥ 11.1 mmol/l as the diagnostic
threshold for glucose results with no provenance informa-
tion. By comparison, a total of 12 288 (8.4%) people had test
values in the range for diabetes, when using ≥7.0 mmol/l as
the diagnostic threshold for glucose results with no prove-
nance information.
Clinical audit
A total of 460 people at the audit practice had a diagnosis of
diabetes. Of these, 37 (8.0%) had Type 1 diabetes and 407
(88.5%) had Type 2 diabetes. Sixteen people had other forms
of diabetes and were excluded from analysis (3.5%): one case
Table 1 Abundance of coded glucose measurements by provenance in the audit practice and the Royal College of General Practitioners Research
and Surveillance Centre
Test provenance
Audit practice RCGP RSC
n % (95% CI) n % (95% CI)
Fasting glucose 68 26.6 (21.1–32.0) 75,044 36.9 (36.7–37.1)
Diagnostic OGTT glucose 1 0.4 (0.0–1.2) 1,245 0.6 (0.6–0.6)
Random glucose 24 9.4 (5.9–12.9) 6,314 3.1 (3.0–3.2)
No provenance specified 164 64.1 (58.2–69.9) 117,893 58.0 (57.8–58.2)
Other provenance specified 0 0.0 (0.0–0.8) 2,854 1.4 (1.4–1.5)
Totals 256 100.0 203,350 100.0
OGTT, oral glucose tolerance test; RCGP RSC, Royal College of General Practitioner Research and Surveillance Centre.
Glucose measurements for the audit practice are the first recorded value for each included patient.
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of pancreatic insufficiency, two cases of steroid-induced
diabetes, three cases of gestational diabetes, three cases
reclassified as diabetes resolved, four cases reclassified as
prediabetes, one case where the diagnosis was never con-
firmed (in a temporarily registered patient) and one erro-
neous diagnosis. Of the included cases (n=444), 181 were
female (40.8%). The mean (range; SD) age was 63.6 (24–99;
14.5) years.
Of those included, 16 (3.6%) patients were either diag-
nosed before moving to the practice or diagnosed in
secondary care. From the remaining 428, the first diagnostic
test was a non-OGTT glucose measurement in 256 cases
(59.8%). In 122 cases it was an HbA1c measurement
(28.5%) and in 50 cases the diagnosis was made using a
formal OGTT (11.7%).
As with the RCGP RSC data, the majority of glucose tests
had no provenance specified (Table 1). A total of 24 results
(9.4%) had no code and therefore would be missed by an
electronic search, which relies solely on pulling data using
Read codes. A similar issue applies with OGTT results; only
one OGTT result had an associated Read code: the remain-
ing 49 results were identified from clinical letters, which are
uploaded as attached documents. These can only be viewed
manually, when searching the patient record.
Of the 164 glucose tests without provenance information,
89 (54.3%) had values between 7.0 and 11.0. These lie
within a diagnostic no-mans-land.
The search identified 41 (16% of initial tests) instances
where a general practitioner questioned the provenance of a
glucose result, and documented this in the patient record. Of
the results questioned by clinicians, 37 (90.2%) used non-
specific Read codes. The remaining four cases where prove-
nance was questioned were when the result was coded with a
fasting Read code.
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FIGURE 1 Distribution of blood glucose values by glucose provenance: (a) fasting glucose, (b) oral glucose tolerance test glucose at two h, (c)
random glucose, and (d) no provenance recorded. The dotted line indicates the diagnostic threshold for diabetes in fasted samples, the dashed line the
diabetes diagnostic threshold for random samples and those taken at two h during a glucose tolerance test.
Table 2 A comparison of the distributions of glucose values by
provenance
Glucose
provenance
Number
of
samples
with
values
Mean (SD),
mmol/l
Median,
mmol/l Skew Kurtosis
Fasting 100 626 5.85 (2.5) 5.2 4.01 22.78
Random 3730 8.54 (4.6) 6.8 1.74 3.33
Not
recorded
69 333 5.50 (1.5) 5.2 4.91 38.32
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Of the 41 cases where a clinician questioned the prove-
nance of the result, 14 (34.1%) had tests repeated. One case
had a substantial number of extra tests; a non-English
speaking patient repeatedly had glucose tests performed;
however, the clinician each time struggled to ascertain
whether the sample was fasting. One repeat test was
undertaken during Ramadan, and again confusion secondary
to poor communication (lack of a translator) meant this also
had to be repeated. This resulted in an extra five tests being
performed and a significant time delay to diagnosis (614
days).
Of the 41 cases where provenance was questioned, 37
(90.2%) had a delay in diagnosis, ranging from 3 to 614 days
(median 30 days; six patients had delays > 200 days).
Over time the use of Read codes at the practice appeared
to change, with an increase in use of codes that include
provenance information from 2009, at which time a review
of glucose testing at the practice had been carried out.
Discussion
The present study highlights two major findings; the majority
of blood glucose results coded (58%) in UK primary care are
lacking provenance information, and this leads to unneces-
sary repeat tests and delayed diagnosis of diabetes.
There are implications from this research for epidemio-
logical studies using glucose measurements drawn from
routine data. Whilst HbA1c results may be used increasingly
for diagnosis, this is not so for retrospective studies. The
distribution of results with no provenance information most
closely resembles that of fasting samples, suggesting that the
majority of these samples are fasting. Making assumptions
about provenance for these samples would result in over- or
underestimation of diabetes prevalence in the population.
The need to repeat tests because of uncertain provenance
wastes doctor and phlebotomist time and is inconvenient for
patients. We recognize that some of the repeat tests may be
attributable to clinicians repeating the tests appropriately
after 3 months to confirm the diagnosis of diabetes.
The major strength of the present investigation is that we
examine the issue of failing to record glucose provenance on
the both a macro and a micro scale.
The RCGP RSC covers a large population. Use of these
data has provided up-to-date and nationally representative
information on the recording of glucose provenance; how-
ever, the importance of this issue is not limited to the UK,
with data provenance being an international issue.
The audit component of this investigation was undertaken
in a single primary care centre with a special interest in
diabetes research, audit and clinical coding and, therefore,
may not be fully representative of the national situation. It is
likely that the coding and management of diabetes in this
practice is better than the national average.
Our clinical audit only included people with a confirmed
diagnosis of diabetes. From this component of the investiga-
tion we are therefore unable to identify if failure in
provenance recorded has led to underdiagnoses of diabetes.
Finally, we do not know what proportion of the poor
data provenance originated in the practice or the labora-
tory. Whilst general practitioners in our audit practice
expressed frustration, we could not reconstruct the data
history to know at what point there was a failure to record
the data required. It might have been failure by the
requesting general practitioner, by the person taking the
blood test or by the laboratory staff; however, it is likely to
have been a combination of all three and the possibility for
this failure should be build out of all elements of the
system.
To the best of our knowledge no previous descriptive
analysis of the provenance of blood glucose tests in a
complete primary care population has been performed. We
have previously reported that glucose provenance was not
recorded in 65% of glucose tests performed for follow-up of
women with gestational diabetes [4], which is similar to the
58% identified in the present study.
With the exception of flagging if the patient is pregnant,
sufficient codes exist to enable the precise labelling of the
provenance of blood glucose tests. The Systematised Nomen-
clature of Medicine Clinical Terms (SNOMED CT), the most
likely terminology to succeed the use of Read codes in the
National Health Service and to be used internationally, also
has the ability to record glucose test provenance [14].
Missing data provenance causes wasting of clinician time
attempting to confirm test provenance with patients, unnec-
essary repeated glucose testing and delayed diagnosis. This
issue could be rectified by increasing the use of existing codes
that record glucose provenance data. Removing existing
codes that are not used or infrequently used (Appendix S1)
would improve clarity. Laboratory test request software
should be set up to specify whether the value is fasted,
random or part of a glucose tolerance test.
With the increasing use of routine data in healthcare
research it is important to identify and manage potential data
quality issues [15,16]. The provenance of blood glucose is
one such challenge that will affect any research that involves
defining a population with diabetes (or a related condition).
Clinical ontologies offer a partial solution to data quality
issues; they have been extended to provide in-depth infor-
mation of the source of data [17].
The issue of the provenance of blood glucose for diabetes
management and control may be less important now, with
the greater use of HbA1c (for which provenance is less
important); however, HbA1c should not be used in children
or women who are currently pregnant and people with
suspected Type 1 diabetes [18], and blood glucose tests with
reliable provenance remain important in healthcare delivery.
In conclusion, the majority of blood glucose tests, per-
formed in primary care, are recorded in clinical record
systems without information about the provenance of the
test. This causes delayed diagnosis of diabetes, unnecessary
ª 2016 The Authors.
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repeated tests and wasted clinician time. Improved clinical
coding in primary care is required.
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